...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
DATE
TIMESTAMP
PRICE
VOLUME
09/25/2024 12:03:01
0.000001
7,680

fuzzy you truly believe this trade? Do the math.

7680 X .000001 = .007 cents.

Bogus trade! A fictitious trade! Manipulation by a broker on the OTC!

 

Koo

Share
New Message
Please login to post a reply